Once-Weekly Insulin vs. Daily Injection

Study finds one is more effective than the other

Translate to Spanish or other 102 languages!

Could a once-weekly insulin injection be on the horizon as a treatment for type 2 diabetes? Image for illustration purposes
Could a once-weekly insulin injection be on the horizon as a treatment for type 2 diabetes? Image for illustration purposes

Medical News Today

- Advertisement -
  • Researchers compared the efficacy of once-weekly and once-daily insulin treatments for type 2 diabetes. 
  • They found that the once-weekly treatment icodec was more effective in lowering blood sugar levels than the standard once-daily injections. 
  • Experts say further studies are needed to confirm the results. 

A new, once-weekly insulin treatment could be a game changer for people with type 2 diabetes, according to a new study.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/type-2-diabetes-once-weekly-insulin-icodec-vs-daily-injection-efficacy?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-07-04&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Smart Strategies to Fight Childhood Obesity Today

As kids head back to school and new routines are established, pediatricians are warning of the long-term consequences of obesity.

FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease.

Why Science Says to Ditch Hydrogen Peroxide for Wounds

Growing up, you may have heard that you should treat open wounds with hydrogen peroxide, but that’s no longer the case.

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.
- Advertisement -